Navigation Links
U.S. Orthopedic Biomaterials Market & Global Biomaterials Industry Reviewed by Products and Applications in New Research Reports
Date:8/5/2013

DALLAS, Aug. 5, 2013 /PRNewswire-iReach/ -- The global biomaterial market is estimated to reach $88.4 billion by 2017 from $44.0 billion in 2012, growing at a CAGR of 15%, whereas in 2012, the U.S. market for orthopedic biomaterials was valued at almost $3.4 billion comprising eight different market segments.  The global biomaterials market report analyzes this industry by products (polymers, metals, ceramics, natural biomaterials) and applications (cardiovascular, orthopedic, dental, plastic surgery, wound healing, tissue engineering, ophthalmology and neurology disorders). Whereas the eight segments covered in the U.S. orthopedic biomaterials market report include orthopedic bone graft substitute, orthopedic growth factor, orthopedic stem cell, orthopedic cell therapy, orthopedic hyaluronic acid viscosupplementation, orthopedic tendon graft, orthopedic cartilage repair and spinal machined bone allograft.

(Photo: http://photos.prnewswire.com/prnh/20130805/MN58459)

The sub-segments included for the analysis of orthopedic biomaterials industry in U.S. are autograft, standard allograft, demineralized bone matrix, synthetic bone graft, xenograft, BMP-2, BMP-7, human embryonic stem cells, mesengchymal stem cells, lumbar spine stem cells, cervical spine stem cells, platelet-rich plasma, orthopedic concentrated bone marrow aspirate, single-injection, three-injection cycle, three/five-injection cycle, BTB graft, soft tissue grafts, ligament and tendon synthetic graft, osteochondral allograft, autologous chondrocyte implantation, meniscal allograft tansplantation, ALIF machined bone allograft, PLIF machined bone allograft, TLIF machined bone allograft and CIF machined bone allograft.

The U.S. Orthopedic Biomaterials Market (http://www.rnrmarketresearch.com/u-s-market-for-orthopedic-biomaterials-market-report.html) report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our "ground up" approach, which includes primary and secondary research methods.  Companies covered in this report: Sanofi-Aventis/Genzyme, Bioventus, DePuy Synthes, Medtronic, Musculoskeletal Transplant Foundation, Stryker, RTI Biologics, NuVasive, Orthofix, LifeNet Health, AlloSource, Integra LifeSciences, Anika Therapeutics, Biomet, Ferring Pharmaceuticals, Exactech, Baxter, Harvest Technologies, Cytomedix, Wright Medical, Community Tissue Services, Olympus Biotech, Fidia, Arteriocyte, Alphatec Spine, Joint Restoration Foundation, University of Miami Tissue Bank, Celling Biosciences and Zimmer. Order a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=82301.

The global biomaterial market witnesses a plethora of growth opportunities. Novel developments of biomaterial for wound healing, plastic surgery, tissue engineering, ophthalmology, and neurology, colossal pool of cardiac patients in Asia, rise of biomaterial market in China and Taiwan, and increased conferences and research-related activities in RoW countries are major factors influencing the growth of the biomaterial market. The burning issues affecting the growth of biomaterial market are challenges to tissue engineering and effect on suppliers by the Biomaterials Access Assurance Act.

The global biomaterial market is dominated by North America, followed by Europe, Asia, and Rest of the World (RoW). North America will continue to lead the biomaterial market in the years to come, followed by Europe. North American market growth is likely to be driven by increasing government investments in biomaterial sector, reimbursements offered by Centers for Medicare and Medicaid Services (CMS) and rising aging population who are the main consumers of biomaterials. The North American biomaterial market is expected to receive a significant push due to phenomenal increase in new products such as botox, botulinum toxins, and hyaluronic-based injectables. This research report (http://www.rnrmarketresearch.com/biomaterials-market-by-products-polymers-metals-ceramics-natural-biomaterials-applications-cardiovascular-orthopedic-dental-plastic-surgery-wound-healing-tissue-engineering-ophthalmolog-market-report.html) categorizes and analyzes the global biomaterial market under two broad segments – type and application. Both of these markets are broken down into segments and sub-segments, providing exhaustive value analysis for the years 2010, 2011, 2012, and forecast to 2017. Each market is comprehensively analyzed at a granular level by geography (North America, Europe, Asia, and Rest of the World) to provide in-depth information on the global scenario.

Companies profiled in this report include: Carpenter Technology Corporation, Heraeus Medical Components, Inc. (Subsidiary Of Heraeus Holding Gmbh), Ulbrich Stainless Steels & Special Metals, Inc., Cam Bioceramics BV, Ceramtec (Subsidiary Of Rockwood Holdings, Inc.), Ceradyne, Inc. (A 3m Company), Kyocera Corporation, Bayer AG, BASF SE, DSM Biomedical, Inc. (Subsidiary Of Royal Dsm N.V.), Evonik Industries AG (A Subsidary Of Rag-Stiftung), Purac Ciomaterials (A CSM Company), Ticona Gmbh (A Celanese Company), Collagen Natrix, Inc., Hycail Finland OY, Landec Corporation, Materion Corporation, Sigma-Aldrich Corporation, Dentsply International, Inc., Noble Biomaterials, Inc., Wright Medical Group, Inc., Depuy Orthopaedics, Inc., Invibio Ltd., Covalon Technologies Ltd., Osteotech, Inc., Biomet, Inc., Orthovita, Inc., Exactech, Inc., Berkeley Advanced Biomaterials, Inc., Morgan Technical Ceramics and Starch Medical, Inc. Order a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=87488.

Explore more reports on the Biomaterials market @ http://www.rnrmarketresearch.com/reports/life-sciences/biotechnology/biomaterials.

About Us:

RnRMarketResearch.com is an online market research reports library of 250,000+ in-depth studies of over 5000 micro markets. Our database includes reports by leading publishers from across the globe. We provide 24/7 online and offline support service to our customers. Explore more reports @ http://www.marketreportsonline.com/.

Media Contact: Priyank Tiwari, RnR Market Research, +1 888 391 5441, sales@rnrmarketresearch.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE RnRMarketResearch.com
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Hanger Orthopedic Group, Inc. announces name change to Hanger, Inc.
2. Innovations for Osteoarthritis, Sports Injuries and Orthopedic Practices
3. U.S. Market for Orthopedic Biomaterials 2012
4. European Markets for Orthopedic Soft Tissue & Sports Medicine 2012
5. U.S. Market for Orthopedic Braces & Support Devices 2012
6. Mindray Medical Completes Acquisition of Dragonbios Orthopedics Business
7. Breg, Inc. Renews Contract to Provide Orthopedic Products to OPGA Members
8. Japanese Market for Orthopedic Soft Tissue Repair & Sports Medicine
9. Brazil Orthopedic Devices Market Outlook to 2018 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others
10. Future Horizons in the Global Orthopedics Market
11. Orthopedic Braces and Supports Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... , May 24, 2016 Celsion Corporation ... development company, today provided an update on its ... clinical trial combining GEN-1, the Company,s DNA-based immunotherapy, ... of newly-diagnosed patients with advanced ovarian cancer who ... surgery.  GEN-1 is an IL-12 DNA plasmid vector ...
(Date:5/24/2016)... KONG , May 24, 2016 ... stent de doble terapia del mundo, introduce catéteres ... arteriovenosa. OrbusNeich, una compañía global especializada ... las vidas, ha expandido su cartera incluyendo productos ... balón JADE™ y Scoreflex™ PTA son los dispositivos ...
(Date:5/24/2016)... Dutch surgeons have launched a ground-breaking medical app to ... patients on a global scale. Medical professionals from Europe ... and the US have already signed up for the app, ... totally secure environment. Education  "Imagine a doctor ... a surgeon at Harvard to treat a bomb victim via live ...
Breaking Medicine Technology:
(Date:5/24/2016)... ... May 24, 2016 , ... Loma Linda University Health (LLUH) has ... and expanded Children’s Hospital. Over 3,000 people looked on as the shovels hit the ... event photo slidehsow. , During the program, Richard H. Hart, MD, DrPH, president, ...
(Date:5/24/2016)... (PRWEB) , ... May 24, 2016 , ... ... to choose the perfect data logger for each job, ensuring the best suited ... offer calibrations of MadgeTech data loggers at their lab in Istanbul. , Metroloji ...
(Date:5/24/2016)... ... May 24, 2016 , ... Growing in popularity, more and more people ... are available and easily accessible. Whether someone chooses to cut gluten out of their ... diet, King Kullen Grocery stocks their shelves with many different gluten-free products all year ...
(Date:5/24/2016)... ... 2016 , ... The number of health insurance policies sold ... last year, according to data in the forthcoming AIS’s Directory of Health Plans: ... a slight decrease in risk-based groups and a slight increase in administrative-services-only/self-funded group ...
(Date:5/24/2016)... ... May 24, 2016 , ... As reported by MassGeneral.org, on May ... transplant in the United States . The 64-year-old patient who received the transplant had ... could restore not only a natural appearance, but also urinary and sexual function for ...
Breaking Medicine News(10 mins):